Quality of life and exercise capacity in obesity and growth hormone deficiency

Neuroendocrinology Letters

Volumn 31, Issue 5, 2010, Pages 700-707

  Olczyk, Joanna ^a   Kokoszko, Agnieszka ^a,b   Lewiński, Andrzej ^a,b   Karbownik Lewińska, Małgorzata ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Growth hormone deficiency; Obesity; QoL AGHDA questionnaire; Quality of life

Indexed keywords

ADULT; ARTICLE; BODY MASS; BORG SCALE FOR RATING PERCIEVED EXERTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; EXERCISE TOLERANCE; FEMALE; GROWTH HORMONE DEFICIENCY; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; MALE; MODIFIED MEDICAL RESEARCH COUNCIL SCALE; OBESITY; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS; RATING SCALE; SIX MINUTE WALKING TEST; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE; WALKING;

EID: 79851469776     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Borg GA (1982). Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 14: 377-381.
2. Butler J, Ciarrochi J (2007). Psychological acceptance and quality of life in the elderly. Qual Life Res. 16: 607-615. (Pubitemid 46474947)
3. Deepak D, Daousi C, Boyland E, Pinkney JH, Wilding JPH, MacFarlane IA (2008). Growth hormone and changes in energy balance in growth hormone deficient adults. Eur J Clin Invest. 38: 622-627.
4. Demirbag R, Yilmaz R, Gur M, Celik H, Guzel S, Selek S, et al (2006). DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int J Clin Pract. 60: 1187-1193. (Pubitemid 44363654)
5. Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A (2006). Growth hormone deficiency in the adult. Pituitary. 9: 305-311. (Pubitemid 44823897)
6. Duval K, Marceau P, Pérusse L, Lacasse Y (2006). An overview of obesity-specific quality of life questionnaires. Obes Rev. 7: 347-360. (Pubitemid 44564306)
7. Fideleff HL, Boquete HR (2004). Growth hormone (GH) deficiency and GH replacement therapy: effects on cardiovascular function. In: Abs R, Feldt-Rasmussen U, editors. Growth hormone deficiency in adults. 10 years of KIMS. Oxford: Oxford PharmaGenesis™ Ltd. p. 149-159.
8. Ghigo E, Aimaretti G, Cornell G (2008). Diagnosis of adult GH deficiency. Growth Horm IGF Res. 18: 1-16.
9. Gotherstrom G, Bengtsson BA, Bosaeus I, Johannsson G, Svensson J (2007). A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab. 92: 1442-1445.
10. Grunberg SM, Groshen S, Steingass S, Zaretsky S, Meyerowitz B (1996). Comparison of conditional quality of life terminology and visual analogue scale measurements. Qual Life Res. 5: 65-72. (Pubitemid 26100504)
11. Hána V (2004). Effects of growth hormone (GH) deficiency and GH replacement on quality of life. In: Abs R, Feldt-Rasmussen U, editors. Growth hormone deficiency in adults. 10 years of KIMS. Oxford: Oxford PharmaGenesis™ Ltd. p. 199-208.
12. Janssen J, van der Lely AJ (2004). Growth hormone and the metabolic syndrome. In: Abs R, Feldt-Rasmussen U, editors. Growth hormone deficiency in adults. 10 years of KIMS. Oxford: Oxford PharmaGenesis™ Ltd. p. 289-297.
13. Karbownik-Lewińska M, Kokoszko A, Lewandowski KC, Shalet SM, Lewiński A (2008). Growth hormone replacement reduces increased lipid peroxidation in growth hormone-deficient adults. Clin Endocrinol (Oxf). 68: 957-964.
14. Karbownik-Lewińska M, Lewiński A, McKenna S, Kokoszko A, Mucha S, Komorowski J, et al. (2008). The Polish version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) - four-stage translation and validation. Pol J Endocrinol. 59: 374-384.
15. Karpoff L, Vinet A, Schuster I, Oudot C, Goret L, Dauzat M, et al (2009). Abnormal vascular reactivity at rest and exercise in obese boys. Eur J Clin Invest. 39: 94-102.
16. Kokoszko A, Karbownik M, Lewiński A (2006). Increased lipid peroxidation in growth hormone-deficient adult patients. Neuro Endocrinol Lett. 27: 225-230. (Pubitemid 43970798)
17. Martínez-Moragón E, Perpiñá M, Belloch A, de Diego A, Martínez-Francés M (2003). Determinants of dyspnea in patients with different grades of stable asthma. J Asthma. 40: 375-382.
18. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, et al (1999). The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res. 8: 373-383. (Pubitemid 29369642)
19. Pischon T, Nöthlings U, Boeing H (2008). Obesity and cancer. Proc Nutr Soc. 67: 128-145. (Pubitemid 351543395)
20. Rasmussen MH (2010). Obesity, growth hormone and weight loss. Mol Cell Endocrinol. 316: 147-153.
21. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 371: 569-578. (Pubitemid 351232031)
22. Ruchala M, Stangierska I, Gurgul E, Stangierski A, Fajfer J, Sowinski J (2010). The effect of octreotide treatment on somatic and psychological symptoms of acromegaly. Neuro Endocrinol Lett. 31: 265-269.
23. Scacchi M, Valassi E, Ascoli P, Cavagnini F (2007). Obesity, hyponutrition and growth hormone. Obe Metab. 3: 68-87.
24. Webb SM, Badia X (2007). Quality of life in growth hormone deficiency and acromegaly. Endocrinol Metab Clin North Am. 36: 221-232. (Pubitemid 46335847)
25. Yancy WS Jr, Almirall D, Maciejewski ML, Kolotkin RL, McDuffie JR, Westman EC (2009). Effects of two weight-loss diets on health-related quality of life. Qual Life Res. 18: 281-289.